BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$27.85 USD
+3.23 (13.12%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $27.78 -0.07 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 21% (53 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.21 | 1.95 | 9.99 |
Current Quarter Estimate | -1.02 | 1.57 | 61.00 |
Year Ago Quarter Estimate | -1.08 | -0.94 | 54.84 |
Next Quarter Estimate | -0.94 | 1.79 | 63.00 |
Next Year Estimate | -2.87 | 6.83 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 37.72 | 21.80 | 15.67 |
Next Year | -16.67 | 7.30 | 11.34 |
Last 5 Years | NA | 0.10 | 8.10 |
Next 5 Years | 26.80 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 3.28 |
Price/Book (MRQ) | NA | 2.01 |
Price/Cash Flow (MRFY) | NA | 11.53 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -207.11% | -71.99% |
Return on Equity (TTM) | NA | -48.41% |
Debt to Equity (MRQ) | -1.59 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.